Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Trial of Epirubicin, Carboplatin and Capecitabine in Adult Cancer Patients

NCT00486356 is registered in ClinicalTrials.gov with University of Nebraska as lead sponsor.

NCT NCT00486356
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00486356 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Trial of Epirubicin, Carboplatin and Capecitabine in Adult Cancer Patients
Lead sponsor
University of Nebraska
Phase
Phase 1
Overall status
Completed
Start date
October 1, 2004
Completion date
January 1, 2010
Enrollment
46 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

extrahepatic bile duct cancer, gallbladder cancer, gastric cancer, liver cancer, unspecified adult solid tumor, protocol specific